MegaIPOs Could Signal Market Top as SpaceX and OpenAI Prep Record Floats Microsoft Appoints New Responsible Tech Lead to Humanize Rapid AI Development SP 500 Edges Higher Led by Healthcare and Tech Communication Services Lags Japans Megabanks Report Record Profits But Analysts Warn of Potential Growth Slowdown Amid Rising Risks Pentagon Discloses Decades of UFO Sightings Orbs Swarming in All Directions Fed Interest Rate Hike Expected as Soon as December Futures Markets Signal After Inflation Data ELS Q1 2026 Earnings Modest EPS Beat and Steady Market Response Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress Cheesecake Factory CAKE Q1 2026 Earnings EPS Beat Driven by Operational Strength Stock Edges Higher RDZN Q1 2026 Earnings Significant EPS Miss Amidst Transition MFAO Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Higher VAL Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Offshore Drilling Market Sprinklr Inc CXM Gains 256 as Stock Tests Key Resistance Level PureCycle Technologies PCT Holds Steady Near Support as Volume Remains Subdued SailPoint Inc SAIL Surges Nearly 5 as Positive Momentum Builds Apple Inc AAPL Hovers Near Flatline Amid Key Support and Resistance Levels Range Capital Acquisition Corp Rights RANGR Holds at 029 Amidst Minimal Volume Andy Burnhams Manchester Spirit Could a Mix of Collectivism and Entrepreneurialism Reshape UK Policy TAOX Q4 2024 Earnings EPS Misses Estimates Amid Operational Challenges PDD Holdings Shares Drop Sharply Key Support Levels Under Pressure REGCP Q1 2026 Earnings Preferred Dividend Coverage Beats Estimates Revenue Data Unavailable MTEX Q3 2023 Earnings Narrow Profit as Stock Gains FHB Q1 2026 Earnings EPS Beats Estimates Amidst Cautious Bank Sector Sentiment INSP Q1 2026 Earnings Wider Loss Misses Estimates Shares Dip JOYY Q4 2025 Earnings EPS Falls Short of Estimates Stock Declines JetBlue Q1 2026 Earnings WiderthanExpected Loss Despite Positive Stock Reaction TCRT Q4 2023 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue